ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

VTRS Viatris Inc

11.57
-0.21 (-1.78%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Viatris Inc VTRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.21 -1.78% 11.57 09:00:00
Open Price Low Price High Price Close Price Previous Close
11.74 11.57 11.75 11.57 11.78
more quote information »

Recent News

Date Time Source Heading
17/4/202406:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
15/4/202422:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
15/4/202420:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
01/4/202421:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
27/3/202421:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
06/3/202412:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202411:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202411:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202411:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202410:11EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:39EDGAR2Form 8-K - Current report
28/2/202422:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
28/2/202417:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
24/2/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202409:18EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
31/1/202408:40EDGAR2Form 8-K/A - Current report: [Amend]
19/1/202422:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
06/1/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:28EDGAR2Form 144 - Report of proposed sale of securities
22/12/202308:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
16/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202309:04EDGAR2Form 8-K/A - Current report: [Amend]
16/12/202309:00EDGAR2Form 8-K - Current report
16/12/202308:45PRNUSViatris Continues its Preparations for Phase 2 of its..
16/12/202308:14EDGAR2Form 8-K - Current report
16/12/202308:12EDGAR2Form 8-K - Current report
16/12/202308:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
15/12/202309:31EDGAR2Form 144 - Report of proposed sale of securities
25/11/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202308:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/11/202305:02EDGAR2Form 144 - Report of proposed sale of securities
15/11/202300:00PRNUSViatris to Participate in the Jefferies London Healthcare..
14/11/202300:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
08/11/202308:39EDGAR2Form 8-K - Current report
08/11/202308:02PRNUSViatris Reports Strong Financial and Operational Results for..
04/11/202307:36EDGAR2Form ARS - Annual Report to Security Holders
04/11/202307:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/11/202307:31EDGAR2Form DEF 14A - Other definitive proxy statements
31/10/202300:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
25/10/202307:32EDGAR2Form 8-K - Current report
25/10/202307:30EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202300:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
21/10/202308:18EDGAR2Form 8-K - Current report
21/10/202308:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
18/10/202323:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
11/10/202300:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..

Your Recent History

Delayed Upgrade Clock